Propanc Biopharma, Inc. (PPCB)

NASDAQ: PPCB · Real-Time Price · USD

1.080

-0.020 (-1.82%)

At close: Aug 21, 2026, 4:00 PM EDT

1.050

-0.030 (-2.78%)

After-hours: Aug 21, 2026, 7:59 PM EDT

Propanc Biopharma Income Statement

Financials in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Selling, General & Admin	18.07	57.05	1.29	1.53	1.73	1.58
Research & Development	0.3	0.22	0.25	0.25	0.26	0.23
Operating Expenses	18.37	57.28	1.54	1.78	1.99	1.81
Operating Income	-18.37	-57.28	-1.54	-1.78	-1.99	-1.81
Interest Expense	-0.66	-0.56	-0.67	-0.53	-0.57	-0.45
Interest & Investment Income	0	0	0	0	0.01	0
Currency Exchange Gain (Loss)	-0.02	-0.09	0.02	0.01	-0.04	0.03
Other Non Operating Income (Expenses)	0.68	-0.12	0.18	-0.53	-0.1	-0.01
EBT Excluding Unusual Items	-18.38	-58.05	-2	-2.83	-2.7	-2.24
Other Unusual Items	0.01	-0.87	0.05	0.04	-0.02	0.1
Pretax Income	-18.36	-58.92	-1.95	-2.79	-2.71	-2.14
Income Tax Expense	-	-	-0.13	-0.13	-0.05	-0.11
Net Income	-18.36	-58.92	-1.82	-2.66	-2.66	-2.03
Preferred Dividends & Other Adjustments	0.93	-	0.19	0.47	0.7	0.39
Net Income to Common	-19.29	-58.92	-2.01	-3.13	-3.36	-2.42
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	1	0	-	-	-	-
Shares Outstanding (Diluted)	1	0	-	-	-	-
Shares Change	1295.84%	-	-	-	-	-
EPS (Basic)	-32.41	-371.22	-	-	-	-
EPS (Diluted)	-32.41	-371.22	-	-	-	-
EPS Growth	-	-	-	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Free Cash Flow	-4.18	-0.41	-0.94	-1.11	-1.44	-1.15
Free Cash Flow Per Share	-7.02	-2.55	-	-	-	-
EBITDA	-18.37	-57.28	-1.54	-1.77	-1.99	-1.81
D&A For EBITDA	0	0	0	0	0	0
EBIT	-18.37	-57.28	-1.54	-1.78	-1.99	-1.81